[1]蒋唯松,周与华△,王义辉,等.血必净注射液对EICU脓毒症患者炎症应激反应和心肌功能的影响*[J].陕西中医,2020,(4):502-504,523.
　JIANG Weisong,ZHOU Yuhua,WANG Yihui,et al.Effect of Xuebijing injection on inflammatory stress response and myocardial function in patients with sepsis of EICU[J].,2020,(4):502-504,523.
点击复制

血必净注射液对EICU脓毒症患者炎症应激反应和心肌功能的影响*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年4期
页码:
502-504,523
栏目:
临床研究
出版日期:
2020-04-05

文章信息/Info

Title:
Effect of Xuebijing injection on inflammatory stress response and myocardial function in patients with sepsis of EICU
文章编号:
DOI:10.3969/j.issn.10007369.2020.04.030
作者:
蒋唯松1;  周与华1△; 王义辉1; 陈春燕2
1.上海交通大学医学院附属瑞金医院急诊科(上海200025); 2.上海交通大学医学院免疫与微生物学系(上海200025)
Author(s):
JIANG Weisong;  ZHOU Yuhua;  WANG Yihui; et al.
Emergency Department,Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine(Shanghai 200025)
关键词:
脓毒症;  血必净注射液;  急性和慢性健康状况评分系统Ⅱ评分;  炎性因子;  心肌功能
Keywords:
Sepsis;  Xuebijing injection;  Acute and chronic health status scoring system Ⅱ;  Inflammatory factors;  Myocardial function
分类号:
R631
文献标志码:
A
摘要:
目的:探讨血必净注射液治疗急诊重症监护室(EICU)脓毒症患者的疗效,以及对机体炎症应激反应和心肌功能的影响。方法:采用随机数字表法将190例脓毒症分为常规组和血必净组,每组均95例。两组均严格按照脓毒症治疗指南(2016年版)给予常规抗脓毒症集束化治疗,血必净组在常规治疗基础上给予血必净注射液治疗,常规组给予等量的0.9%氯化钠注射液。观察两组治疗前和治疗7 d后急性和慢性健康状况评分系统Ⅱ(APACHE Ⅱ)评分,检测并比较治疗前后血清炎性因子肿瘤坏死因子-α(TNF-α)、超敏C-反应蛋白(hs-CRP)、降钙素原(PCT)、白介素-6(IL-6)和心肌损伤标志物血肌钙蛋白I(cTn I)、肌酸激酶同工酶(CK-MB)水平,统计两组EICU住院时间和28 d死亡率。结果:两组治疗7 d后血清TNF-α、hs-CRP、PCT、IL-6和cTn I、CK-MB水平均明显下降(P<0.05),且治疗组治疗7 d后上述炎性因子和心肌功能指标水平显著低于常规组,差异有统计学意义(P<0.05)。治疗组治疗7 d后APACHEⅡ评分明显低于常规组,EICU住院时间较常规组明显缩短,差异有统计学意义(P<0.05),两组28 d病死率比较差异无统计学意义(P>0.05)。结论:常规对症治疗联合血必净注射液能有效减轻脓毒症患者机体炎症应激反应和保护心肌功能,对改善病情程度和缩短EICU住院时间有一定价值。
Abstract:
Objective:To investigate the therapeutic effect of Xuebijing injection on sepsis patients in emergency intensive care unit(EICU),and its effect on inflammatory stress response and myocardial function.Methods:190 cases of sepsis were divided into routine group and Xuebijing group with 95 cases in each group.Both groups were treated with routine anti sepsis cluster therapy in strict accordance with the sepsis treatment guidelines(2016 version).Xuebijing group was treated with Xuebijing injection on the basis of routine treatment,and the routine group was treated with 0.9% sodium chloride injection.The scores of acute and chronic health status scoring system Ⅱ(APACHE Ⅱ)were observed before and 7 days after treatment in the two groups.The levels of serum inflammatory factors,tumor necrosis factor -α(TNF -α),high-sensitivity C-reactive protein(hs CRP),procalcitonin(PCT),interleukin-6(IL-6),cardiac injury markers,serum cardiac troponin I(cTnI),creatine kinase isoenzyme(CK-MB)were measured and compared before and after treatment in the two groups hospital time and 28 day mortality.Results:The levels of TNF-α,hs CRP,PCT,IL-6,cTnI and CK-MB in the two groups decreased significantly after 7 days of treatment(P<0.05),After 7 days of treatment,the levels of inflammatory factors and myocardial function indexes in the treatment group were significantly lower than those in the control group(P<0.05).After 7 days of treatment,APACHE Ⅱ score in the treatment group was significantly lower than that in the conventional group,EICU hospitalization time was significantly shorter than that in the conventional group,the difference was statistically significant(P <0.05),and there was no statistically significant difference in 28 day mortality between the two groups(P>0.05).Conclusion:the routine symptomatic treatment combined with Xuebijing injection can effectively reduce the inflammatory stress response and protect the myocardial function of sepsis patients,and has significant value in improving the degree of illness and shortening the length of EICU hospitalization.

参考文献/References:

[1] 甄军海,李 莉.脓毒症心肌损伤生物标志物的研究进展[J].中华危重病急救医学,2018,30(7):699-702.±
[2] 梁 群,关迪新,车思桦.血必净注射液治疗脓毒症的研究进展[J].天津中医药,2019,36(7):641-644.±
[3] 江利冰,李瑞杰.2016年脓毒症与脓毒性休克处理国际指南[J].中华急诊医学杂志,2017,26(3):263-266.±
[4] 陈 建,张 勇.血必净注射液对脓毒症患者的炎性反应和凝血功能的影响[J].湖南师范大学学报:医学版,2016,13(2):105-107.
[5] 高 莉,於建鹏,王钢胜,等.血必净对重症脓毒症和脓毒症休克时BNP、TnT及TnI水平的影响[J].河北医药,2016,38(19):2930-2932.
[6] 戴 丽,周 斌.心脏相关标志物等指标联合PCT评估脓毒症患儿病情的临床价值[J].中国妇幼健康研究,2018,29(6):744-747.
[7] 张寒钰,邓彦俊,李振华,等.心肌标志物及超声心动图对高龄脓毒症患者预后的意义[J].中国医师杂志,2018,20(5):644-648.
[8] 谢浩荣,王 恺,周 杰.血必净注射液对肝细胞癌患者肝切除术后炎症反应及肝功能的影响[J].中华肝胆外科杂志,2018,24(11):733.
[9] 郭利民.血必净注射液治疗老年重症肺炎疗效及对患者肠黏膜屏障与氧供状态的影响[J].陕西中医,2019,40(6):700-704.
[10] 王 薇,张玉想,李宏山,等.血必净注射液对脓毒症所致急性肾损伤的内皮保护作用[J].解放军医学杂志,2017,42(3):202-206.
[11] 张红玉,王 佳,孙晓靖,等.脓毒症患者血清降钙素原、B型钠尿肽的变化及其临床意义[J].陕西医学杂志,2016,45(4):408-410.
[12] 张 萌,方 悦,赵 正.血必净注射液联合持续性肾脏替代治疗脓毒症合并急性肾损伤患者的疗效[J].中国医师杂志,2019,21(8):1239-1240.
[13] 曹广科,赵玉良,周秀梅,等.血液净化联合血必净对脓毒症患者凝血、免疫、炎症及血管因子的影响[J].海南医学院学报,2019,25(13):994-998.
[14] 张 雷.益气扶正法对脓毒症患者炎症反应及凝血功能的影响[J].陕西中医,2016,37(10):1381-1382.
[15] 陈 维.血必净联合乌司他丁对脓毒症患者内环境稳态的影响[J].海南医学院学报,2019,25(13):999-1002.

相似文献/References:

[1]李 军.大黄附子汤治疗危重脓毒症疗效及对患者胃肠功能改善研究[J].陕西中医,2019,(6):718.
　LI Jun..Research of Dahuang Fuzi prescription in the treatment of patients with severe sepsis improving symptoms signs and gastrointestinal function[J].,2019,(4):718.
[2]荆志强,魏维强,谷 俊,等.通腑宣肺汤对脓毒症急性肺损伤大鼠保护机制的研究*[J].陕西中医,2019,(8):987.
　JING Zhiqiang,WEI Weiqiang,GU Jun,et al.Study on the protective mechanism of the Tongfu Xuanfei decoction in sepsis rats with acute lung injury[J].,2019,(4):987.
[3]张育芳,张 谦△,王忆梅.中医方剂在脓毒症辅助治疗中的辨证应用*[J].陕西中医,2019,(8):1105.
　ZHANG Yufang,ZHANG Qian,WANG Yimei..Dialectical application of traditional Chinese medicine prescription in adjuvant treatment of sepsis[J].,2019,(4):1105.
[4]张吉丹,顼志兵△.健脾消胀方脐部敷贴治疗脓毒症胃肠功能障碍理论研究*[J].陕西中医,2019,(12):1745.
[5]林柏柏,沈梦雯,钱义明,等.从“痰饮”论治脓毒症毛细血管渗漏综合征[J].陕西中医,2021,(2):222.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.021]
　LIN Baibai,SHEN Mengwen,QIAN Yiming,et al.Treatment of sepsis capillary leakage syndrome from “phlegm and fluid”[J].,2021,(4):222.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.021]
[6]王煜辉,董晓斌.脓毒症相关五脏水气病理论探讨[J].陕西中医,2021,(3):353.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.022]
[7]龙 敏,张玉琴,岳 煜,等.黄连解毒汤联合西药治疗脓毒症心肌损伤疗效研究[J].陕西中医,2022,(3):329.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.014]
　LONG Min,ZHANG Yuqin,YUE Yu,et al.Study on clinical efficacy of Huanglian Jiedu decoction combined with western medicine on myocardial injury caused by sepsis[J].,2022,(4):329.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.014]
[8]董学广,傅晓夏,陈秀美,等.解毒通腑泻浊汤保留灌肠对脓毒症合并急性肾损伤患者微循环及血清炎性应激指标的影响[J].陕西中医,2022,(10):1388.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.015]
[9]钟敏林,周仙仕,李 俊,等.血流感染脓毒症患者687例临床特征、中医证素分布及其与预后的相关性分析[J].陕西中医,2022,(10):1392.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.016]
　ZHONG Minlin,ZHOU Xianshi,LI Jun,et al.Clinical characteristics,distribution of TCM syndrome elements and their correlation with prognosis in 687 patients with sepsis and bloodstream infection[J].,2022,(4):1392.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.016]
[10]徐 敏,王建伟.大黄脐贴治疗脓毒症胃肠功能障碍临床研究[J].陕西中医,2022,(11):1531.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.009]
　XU Min,WANG Jianwei.Clinical observation of rhubarb umbilical patch in the treatment of gastrointestinal dysfunction in sepsis[J].,2022,(4):1531.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.009]

备注/Memo

备注/Memo:
*上海市科学技术委员会科研计划项目(17ZR1415900)
更新日期/Last Update: 2020-04-13